Exploratory Investigation of Biomarker Candidates for Suicide in Schizophrenia and Bipolar Disorder
Preliminary Findings of Altered Neurosteroid Levels
Abstract
Background: Clozapine and lithium increase neurosteroids in rodents, and both drugs demonstrate antisuicidal actions. We therefore hypothesized that neurosteroid levels may be reduced in patients with schizophrenia or bipolar disorder who completed suicide. Aims: To investigate neurosteroid levels in the parietal cortex and posterior cingulate in schizophrenia and bipolar patients who died by suicide, and compare them with patients with these disorders who died of other causes. Method: Neurosteroid levels were quantified by gas chromatography/mass spectrometry in the parietal cortex and posterior cingulate. Mann–Whitney analyses were conducted in exploratory post hoc analyses to investigate neurosteroids as possible biomarker candidates for suicide. Results: The study showed that pregnenolone was significantly decreased in the parietal cortex in the combined group of patients with schizophrenia or bipolar disorder who died by suicide (n = 13) compared with patients with these disorders who died of other causes (n = 17, p = .02). Pregnenolone levels were also lower in the parietal cortex in the individual group of schizophrenia patients who died by suicide (n = 4) compared with schizophrenia patients who died of other causes (n = 11) p = .04). Conclusion: Pregnenolone alterations may be relevant to the neurobiology of suicide in schizophrenia and bipolar disorder.
References
2007). Treatment with lithium, alone or in combination with olanzapine, relieves oxidative stress but increases atherogenic lipids in bipolar disorder. Tohoku Journal of Experimental Medicine, 213(1), 79–87.
(2000). Dehydroepiandrosterone prevents oxidative injury induced by transient ischemia/reperfusion in the brain of diabetic rats. Diabetes, 49(11), 1924–1931.
(2008). Serum leptin and cholesterol values in violent and non-violent suicide attempters. Psychiatry Research, 158(1), 87–91.
(2001). A double-blind comparative study of clozapine and risperidone in the management of severe chronic schizophrenia. American Journal of Psychiatry, 158(8), 1305–1313.
(2006). Decreased risk of suicides and attempts during long-term lithium treatment: A meta-analytic review. Bipolar Disorders, 8(5 Pt 2), 625–639.
(1997). Protective effect of dehydroepiandrosterone against copper-induced lipid peroxidation in the rat. Free Radical Biology and Medicine, 22(7), 1289–1294.
(1994). Effects of clozapine on positive and negative symptoms in outpatients with schizophrenia. American Journal of Psychiatry, 151(1), 20–26.
(2001). Effectiveness of second-generation antipsychotics in patients with treatment-resistant schizophrenia: A review and meta-analysis of randomized trials. American Journal of Psychiatry, 158(4), 518–526.
(2006). Neurosteroids as endogenous inhibitors of neuronal cell apoptosis in aging. Annals of the New York Academy of Sciences, 1088, 139–152.
(2004). Dehydroepiandrosterone and allopregnanolone protect sympathoadrenal medulla cells against apoptosis via antiapoptotic Bcl-2 proteins. Proceedings of the National Academy of Sciences of the United States of America, 101(21), 8209–8214.
(1999). Treatment-resistant schizophrenic patients respond to clozapine after olanzapine non-response. Biological Psychiatry, 46(1), 73–77.
(2007). Low plasma cholesterol levels in suicidal males: A gender- and body mass index-matched case-control study of suicide attempters and nonattempters. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 31(4), 901–905.
(2008). Trait aggression in suicide attempters: A pilot study. Psychiatry and Clinical Neurosciences, 62(3), 352–354.
(2007). Cholesterol and suicide attempts: A prospective study of depressed inpatients. Psychiatry Research, 152(1), 11–20.
(1994). CSF neuroactive steroids in affective disorders: Pregnenolone, progesterone, and DBI. Biological Psychiatry, 35(10), 775–780.
(2004). Progesterone and allopregnanolone reduce inflammatory cytokines after traumatic brain injury. Experimental Neurology, 189(2), 404–412.
(1988). Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine. Archives of General Psychiatry, 45(9), 789–796.
(2001). Clozapine and haloperidol in moderately refractory schizophrenia: A 6-month randomized and double-blind comparison. Archives of General Psychiatry, 58(10), 965–972.
(2009). Lithium’s antisuicidal efficacy: Elucidation of neurobiological targets using endophenotype strategies. Annual Review of Pharmacology and Toxicology, 49, 175–198.
(2007). Cholesterol content in brains of suicide completers. International Journal of Neuropsychopharmacology, 10(2), 159–166.
(2008). Effects of neurosteroids on hydrogen peroxide- and staurosporine-induced damage of human neuroblastoma SH-SY5Y cells. Journal of Neuroscience Research, 86(6), 1361–1370.
(2002). Serum cholesterol levels and suicide: A meta-analysis. Suicide and Life-Threatening Behavior, 32(3), 333–346.
(2006). Randomized controlled trial of effect of prescription of clozapine versus other second-generation antipsychotic drugs in resistant schizophrenia. Schizophrenia Bulletin, 32(4), 715–723.
(2007). Serum concentrations of antioxidant vitamins and carotenoids are low in individuals with a history of attempted suicide. Nutritional Neuroscience, 10(1–2), 51–58.
(2009). Allopregnanolone treatment delays cholesterol accumulation and reduces autophagic/lysosomal dysfunction and inflammation in Npc1-/- mouse brain. Brain Research, 1270, 140–151.
(2007). Oxidative stress parameters in unmedicated and treated bipolar subjects during initial manic episode: A possible role for lithium antioxidant effects. Neuroscience Letters, 421(1), 33–36.
(2009). Clozapine protects PC-12 cells from death due to oxidative stress induced by hydrogen peroxide via a cell-type specific mechanism involving inhibition of extracellular signal-regulated kinase phosphorylation. Brain Research, 1283, 14–24.
(2007). Platelet serotonin and serum cholesterol concentrations in suicidal and non-suicidal male patients with a first episode of psychosis. Psychiatry Research, 150(1), 105–108.
(2000). Neurosteroid modulation of embryonic neuronal survival in vitro following anoxia. Brain Research, 871(1), 104–112.
(2006). Clozapine markedly elevates pregnenolone in rat hippocampus, cerebral cortex, and serum: Candidate mechanism for superior efficacy? Pharmacology, Biochemistry and Behavior, 84(4), 598–608.
(2006). Olanzapine and fluoxetine administration and coadministration increase rat hippocampal pregnenolone, allopregnanolone and peripheral deoxycorticosterone: Implications for therapeutic actions. Pharmacology, Biochemistry and Behavior, 84(4), 609–617.
(2006). Neuroactive steroids are altered in schizophrenia and bipolar disorder: Relevance to pathophysiology and therapeutics. Neuropsychopharmacology, 31(6), 1249–1263.
(2006). The neurosteroid allopregnanolone is reduced in prefrontal cortex in Alzheimer’s disease. Biological Psychiatry, 60(12), 1287–1294.
(2008). Neuroactive steroids, mood stabilizers, and neuroplasticity: Alterations following lithium and changes in Bcl-2 knockout mice. International Journal of Neuropsychopharmacology, 11(4), 547–552.
(2005). Social isolation stress-induced aggression in mice: A model to study the pharmacology of neurosteroidogenesis. Stress, 8(2), 85–93.
(2006). Effectiveness of clozapine versus olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia who did not respond to prior atypical antipsychotic treatment. American Journal of Psychiatry, 163(4), 600–610.
(2003). Clozapine treatment for suicidality in schizophrenia: International Suicide Prevention Trial (InterSePT). Archives of General Psychiatry, 60(1), 82–91.
(2005). Clozapine diminishes suicidal behavior: A retrospective evaluation of clinical records. Journal of Clinical Psychiatry, 66(4), 534–538.
(1997). Potentially predictive and manipulable blood serum correlates of aging in the healthy human male: Progressive decreases in bioavailable testosterone, dehydroepiandrosterone sulfate, and the ratio of insulin-like growth factor 1 to growth hormone. Proceedings of the National Academy of Sciences of the United States of America, 94(14), 7537–7542.
(2008). Cerebrospinal fluid dehydroepiandrosterone levels are correlated with brain dehydroepiandrosterone levels, elevated in Alzheimer’s disease, and related to neuropathological disease stage. Journal of Clinical Endocrinology and Metabolism, 93(8), 3173–3178.
(2008). Low serum cholesterol may be associated with suicide attempt history. Journal of Clinical Psychiatry, 69(12), 1920–1927.
(1992). Clinical and biologic response to clozapine in patients with schizophrenia. Crossover comparison with fluphenazine. Archives of General Psychiatry, 49(5), 345–353.
(2003). In socially isolated mice, the reversal of brain allopregnanolone down-regulation mediates the anti-aggressive action of fluoxetine. Proceedings of the National Academy of Sciences of the United States of America, 100(4), 2035–2040.
(2004). Protective effect of pregnanolone against lipoperoxidation and free radicals generation induced in hypothalamus of ovariectomized rats submitted to CO2 exposure. Pharmacology, Biochemistry and Behavior, 78(2), 191–197.
(1995). Pregneolone – from Selye to Alzheimer and a model of the pregnenolone sulfate binding site on the GABAA receptor. Biochemical Pharmacology, 49(1), 1–16.
(2006). No relationship between serum cholesterol and suicidal ideation and depression in African-American diabetics. Archives of Suicide Research, 10(1), 11–14.
(2005). Dehydroepiandrosterone monotherapy in midlife-onset major and minor depression. Archives of General Psychiatry, 62(2), 154–162.
(2008). Depression and suicidal behavior in alcohol abusing adolescents: Possible role of selenium deficiency. Minerva Pediatrica, 60(2), 201–209.
(2000). The stanley foundation brain collection and neuropathology consortium. Schizophrenia Research, 44(2), 151–155.
(2002). Newer atypical antipsychotic medication in comparison to clozapine: A systematic review of randomized trials. Schizophrenia Research, 56(1–2), 1–10.
(1996). Fluoxetine-elicited changes in brain neurosteroid content measured by negative ion mass fragmentography. Proceedings of the National Academy of Sciences of the United States of America, 93(22), 12599–12604.
(1998). Increase in the cerebrospinal fluid content of neurosteroids in patients with unipolar major depression who are receiving fluoxetine or fluvoxamine. Proceedings of the National Academy of Sciences of the United States of America, 95(6), 3239–3244.
(2007). Neurosteroids reduce inflammation after TBI through CD55 induction. Neuroscience Letters, 425(2), 94–98.
(2009). Differences in cholesterol and metabolic syndrome between bipolar disorder men with and without suicide attempts. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 33(1), 109–112.
(1999). Evidence of clozapine’s effectiveness in schizophrenia: A systematic review and meta-analysis of randomized trials. American Journal of Psychiatry, 156(7), 990–999.
(2005). The neurosteroid allopregnanolone promotes proliferation of rodent and human neural progenitor cells and regulates cell-cycle gene and protein expression. Journal of Neuroscience, 25(19), 4706–4718.
(1999). Double-blind treatment of major depression with dehydroepiandrosterone. American Journal of Psychiatry, 156(4), 646–649.
(2006). Anti-apoptotic effects of allopregnanolone on P19 neurons. European Journal of Neuroscience, 23(1), 43–54.
(